QA-102
- Generic Name
- QA-102
QA102 Phase II Study in Subjects With Dry AMD
Phase 2
Completed
- Conditions
- Dry Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2022-09-13
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Smilebiotek Zhuhai Limited
- Target Recruit Count
- 150
- Registration Number
- NCT05536752
- Locations
- 🇺🇸
Texas Retina Associates - Plano, Plano, Texas, United States
QA102 Phase 1 Study in Healthy Young and Older Adult Subjects
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Smilebiotek Zhuhai Limited
- Target Recruit Count
- 69
- Registration Number
- NCT04894071
- Locations
- 🇺🇸
Covance Clinical Research Unit Inc., Madison, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath